查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1918114

关节间隔物市场 - 2026-2031 年预测

Joint Spacer Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 149 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计关节间隔物市场将从 2025 年的 15.18 亿美元成长到 2031 年的 21.57 亿美元，复合年增长率为 6.03%。

全球关节间隔器市场预计在预测期内将保持稳定成长，这主要归因于整形外科植入手术数量的增加以及假体关节感染（PJI）的持续挑战。关节间隔器（无论是活动式或预製式）是一种载有抗生素的骨水泥装置，旨在两阶段关节重建手术的两个阶段之间维持关节的临时活动度和功能。初次膝关节、髋关节和肩关节关节重建手术数量的增加与PJI发病率的上升直接相关，从而导致重新置换手术中对可靠的间隔器系统有着持续的需求。

关键成长要素包括持续的产品创新，重点在于预製和移动式间隔器；扩大两阶段重新置换通讯协定的适应症；并将先进抗生素整合到间隔器设计中。製造商正优先提供即用型系统，这些系统具有标准化的尺寸、更高的机械稳定性以及优化的局部抗生素释放曲线。这些改进满足了外科医生在处理复杂感染关节病例时对可重复结果的需求。

从地理上看，由于骨关节炎的高发病率、运动和肥胖相关关节损伤数量的增加，以及新一代间隔物技术监管核准的强劲进展，预计北美将在整个预测期内保持其市场主导地位。该地区受益于有利的医保报销政策和领先的整形外科製造商的大量研发投入，从而推动了先进技术植入的快速普及。

在生产环境中，成熟的现成系统继续发挥核心作用：

  • Synicem™ 间隔器系列产品提供含抗生素的即用型产品，适用于髋关节、膝关节和肩关节翻修重新置换。这些装置旨在维持关节间隙，促进感染控制，并在两阶段通讯协定中提供中等程度的软组织张力支撑。
  • Spacer®-G 是一种广泛使用的预製庆大霉素髋关节间隔器，采用不銹钢芯加固，有多种头部直径（46-60 毫米）和柄长可供选择，可在感染性重新置换置换术中提供一致的承重能力和可控的抗生素释放。

竞争格局的特点是产品线持续扩张，并策略性地聚焦于感染控制解决方案。领先的製造商正投资于多孔涂层和奈米技术增强表面，以在适当情况下促进生物整合，同时保持其高剂量局部抗生素递送的核心功能。併购和共同开发契约仍然是巩固市场地位和加速推出下一代间隔物平台的常用策略。

儘管有许多有利因素，但由于其他感染控制方法的普及，包括单阶段重新置换通讯协定和某些患者群体中不依赖间隔物的抗菌策略，市场仍面临许多限制。这些替代方案可能会限制该产品在某些临床场景和治疗方法不同的地区得到应用。

总体而言，受初次关节重建数量稳步增长、假体周围感染问题持续存在以及临时植入解决方案技术不断进步的推动，关节间隔器市场预计将持续扩张。北美在市场份额和创新速度方面继续保持主导，Synicem™ 和 Spacer®-G 等成熟的现成系统在全球两阶段重新置换手术中保持着较高的临床认可度。

本报告的主要优势：

  • 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略实现市场渗透的潜力。
  • 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
  • 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
  • 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

  • 历史资料（2021-2025 年）和预测资料（2026-2031 年）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按业务板块和地区（国家）分類的收入成长和预测分析
  • 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

第五章 依类型分類的关节间隔物市场

  • 介绍
  • 水泥固定
  • 非水泥型

第六章 依关节类型分類的关节间隔物市场

  • 介绍
  • 膝关节
  • 髋关节
  • 肩关节
  • 其他的

第七章 依最终使用者分類的关节间隔物市场

  • 介绍
  • 医院
  • 门诊手术中心
  • 其他的

第八章 各地区关节间隔物市场

  • 介绍
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章：竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第十章：公司简介

  • Abbott
  • Zimmer Biomet
  • Johnson & Johnson
  • Stryker Corporation
  • Heraeus Holding
  • Enovis Corporation
  • Exactech, Inc.
  • Arthrex Inc.
  • B. Braun SE
  • Tecres SpA

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 分析方法
  • 简称
简介目录
Product Code: KSI061615586

The joint spacer market is expected to grow at a 6.03% CAGR, achieving USD 2.157 billion in 2031 from USD 1.518 billion in 2025.

The global joint spacer market is projected to grow at a steady pace during the forecast period, driven primarily by the increasing volume of orthopedic implantation procedures and the persistent challenge of prosthetic joint infection (PJI). Joint spacers-whether articulating or prefabricated-are antibiotic-loaded, bone-cement devices designed to maintain temporary joint mobility and function between stages of two-stage revision arthroplasty. Rising rates of primary knee, hip, and shoulder replacements directly correlate with increased PJI incidence, creating sustained demand for reliable spacer systems in revision surgery.

Key growth drivers include continued product innovation focused on prefabricated and articulating spacers, expanding indications for two-stage revision protocols, and the integration of advanced antibiotics into spacer designs. Manufacturers are prioritizing ready-to-use systems that offer standardized sizing, improved mechanical stability, and optimized local antibiotic elution profiles. These enhancements address surgeon demand for reproducible outcomes while managing complex infected joint cases.

Geographically, North America is expected to maintain market dominance throughout the forecast period. Contributing factors include a high prevalence of osteoarthritis, elevated rates of sports- and obesity-related joint injuries, and a robust pipeline of regulatory approvals for next-generation spacer technologies. The region benefits from rapid adoption of technologically advanced implants, supported by favorable reimbursement frameworks and concentrated R&D investment from leading orthopedic manufacturers.

In the product landscape, established prefabricated systems continue to play a central role:

  • The Synicem(TM) spacer range provides ready-to-use, antibiotic-loaded options for hip, knee, and shoulder revisions. These devices are engineered to preserve articular space, facilitate infection control, and support soft-tissue tension during the interim period of two-stage protocols.
  • Spacer(R)-G remains a widely utilized prefabricated gentamicin-loaded hip spacer. Reinforced with a stainless-steel core and available in multiple head diameters (46-60 mm) and stem lengths, it delivers consistent load-bearing capacity and controlled antibiotic release in infected total hip arthroplasty revisions.

Competitive dynamics are characterized by ongoing portfolio expansion and strategic focus on infection-management solutions. Leading manufacturers are investing in porous-coated and nanotechnology-enhanced surfaces to promote biological integration where appropriate, while maintaining the core function of high-dose local antibiotic delivery. Mergers, acquisitions, and collaborative development agreements remain prevalent tactics to strengthen market positioning and accelerate the introduction of next-generation spacer platforms.

Despite favorable tailwinds, the market faces constraints from the availability of alternative infection-management approaches, including single-stage revision protocols and non-spacer-based antimicrobial strategies in select patient cohorts. These alternatives may temper adoption in certain clinical scenarios or geographic regions with differing treatment preferences.

Overall, the joint spacer segment is poised for sustained expansion, underpinned by the inexorable rise in primary joint replacement volumes, the unchanging burden of periprosthetic infection, and continuous technological refinement of temporary implant solutions. North America will continue to lead both in market share and innovation velocity, while established prefabricated systems such as Synicem(TM) and Spacer(R)-G retain strong clinical acceptance in two-stage revision pathways worldwide.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Joint Spacer Market Segmentation:

  • By Type
  • Cemented
  • Non-Cemented
  • By Joint Type
  • Knee Joint
  • Hip Joint
  • Shoulder Joint
  • Others
  • By End-User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. JOINT SPACER MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Cemented
  • 5.3. Non-Cemented

6. JOINT SPACER MARKET BY JOINT TYPE

  • 6.1. Introduction
  • 6.2. Knee Joint
  • 6.3. Hip Joint
  • 6.4. Shoulder Joint
  • 6.5. Others

7. JOINT SPACER MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Ambulatory Surgical Centers
  • 7.4. Others

8. JOINT SPACER MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Abbott
  • 10.2. Zimmer Biomet
  • 10.3. Johnson & Johnson
  • 10.4. Stryker Corporation
  • 10.5. Heraeus Holding
  • 10.6. Enovis Corporation
  • 10.7. Exactech, Inc.
  • 10.8. Arthrex Inc.
  • 10.9. B. Braun SE
  • 10.10. Tecres S.p.A.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations